These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38239047)

  • 41. Reciprocal change in Glucose metabolism of Cancer and Immune Cells mediated by different Glucose Transporters predicts Immunotherapy response.
    Na KJ; Choi H; Oh HR; Kim YH; Lee SB; Jung YJ; Koh J; Park S; Lee HJ; Jeon YK; Chung DH; Paeng JC; Park IK; Kang CH; Cheon GJ; Kang KW; Lee DS; Kim YT
    Theranostics; 2020; 10(21):9579-9590. PubMed ID: 32863946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive
    Schwenck J; Schörg B; Fiz F; Sonanini D; Forschner A; Eigentler T; Weide B; Martella M; Gonzalez-Menendez I; Campi C; Sambuceti G; Seith F; Quintanilla-Martinez L; Garbe C; Pfannenberg C; Röcken M; la Fougere C; Pichler BJ; Kneilling M
    Theranostics; 2020; 10(2):925-937. PubMed ID: 31903160
    [No Abstract]   [Full Text] [Related]  

  • 43. PD1 blockade alters cell-cycle distribution and affects 3'-deoxy-3'-[
    Suzuki M; Matsuda T; Nakajima K; Yokouchi Y; Kuge Y; Ogawa M
    Ann Nucl Med; 2022 Nov; 36(11):931-940. PubMed ID: 35969311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
    Tate CR; Rhodes LV; Segar HC; Driver JL; Pounder FN; Burow ME; Collins-Burow BM
    Breast Cancer Res; 2012 May; 14(3):R79. PubMed ID: 22613095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orthotopic and heterotopic triple negative breast cancer preclinical murine models: A tumor microenvironment comparative.
    Santana-Krímskaya SE; Kawas JR; Zarate-Triviño DG; Ramos-Zayas Y; Rodríguez-Padilla C; Franco-Molina MA
    Res Vet Sci; 2022 Dec; 152():364-371. PubMed ID: 36108549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
    Yu M; Chen Y; Wang Z; Ding X
    Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis.
    Atiya HI; Dvorkin-Gheva A; Hassell J; Patel S; Parker RL; Hartstone-Rose A; Hodge J; Fan D; Ramsdell AF
    Anticancer Res; 2019 May; 39(5):2277-2287. PubMed ID: 31092419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hafnium-doped hydroxyapatite nanoparticles with ionizing radiation for lung cancer treatment.
    Chen MH; Hanagata N; Ikoma T; Huang JY; Li KY; Lin CP; Lin FH
    Acta Biomater; 2016 Jun; 37():165-73. PubMed ID: 27060620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity.
    Zhang J; Wei L; Ma X; Wang J; Liang S; Chen K; Wu M; Niu L; Zhang Y
    Acta Biomater; 2023 Aug; 166():470-484. PubMed ID: 37253416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
    Kukuk D; Reischl G; Raguin O; Wiehr S; Judenhofer MS; Calaminus C; Honndorf VS; Quintanilla-Martinez L; Schönberger T; Duchamp O; Machulla HJ; Pichler BJ
    J Nucl Med; 2011 Oct; 52(10):1654-63. PubMed ID: 21859811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monitoring Src status after dasatinib treatment in HER2+ breast cancer with
    McKnight BN; Viola-Villegas NT
    Breast Cancer Res; 2018 Oct; 20(1):130. PubMed ID: 30359299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.
    Cullinane C; Dorow DS; Jackson S; Solomon B; Bogatyreva E; Binns D; Young R; Arango ME; Christensen JG; McArthur GA; Hicks RJ
    J Nucl Med; 2011 Aug; 52(8):1261-7. PubMed ID: 21764800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    Fricke IB; De Souza R; Costa Ayub L; Francia G; Kerbel R; Jaffray DA; Zheng J
    PLoS One; 2018; 13(5):e0196892. PubMed ID: 29723251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pyruvate-lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1-
    van Heijster FHA; Heskamp S; Breukels V; Veltien A; Franssen GM; Jansen KCFJ; Boerman OC; Schalken JA; Scheenen TWJ; Heerschap A
    NMR Biomed; 2020 Oct; 33(10):e4362. PubMed ID: 32662543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness.
    Shah L; Latif A; Williams KJ; Tirella A
    Acta Biomater; 2022 Oct; 152():273-289. PubMed ID: 36087866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Claudin-4 SPECT Imaging Allows Detection of Aplastic Lesions in a Mouse Model of Breast Cancer.
    Mosley M; Knight J; Neesse A; Michl P; Iezzi M; Kersemans V; Cornelissen B
    J Nucl Med; 2015 May; 56(5):745-51. PubMed ID: 25840973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stromal integrin α11-deficiency reduces interstitial fluid pressure and perturbs collagen structure in triple-negative breast xenograft tumors.
    Smeland HY; Lu N; Karlsen TV; Salvesen G; Reed RK; Stuhr L
    BMC Cancer; 2019 Mar; 19(1):234. PubMed ID: 30876468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer.
    Li Z; Belitzky E; Blaha O; Cavaliere A; Katz SR; Aboian M; Melegari L; Rajabimoghadam K; Kurpiewski S; Zhu X; Marquez-Nostra B
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiandrogen Therapy Radiosensitizes Androgen Receptor-Positive Cancers to
    Singaravelu I; Spitz H; Mahoney M; Dong Z; Kotagiri N
    J Nucl Med; 2022 Aug; 63(8):1177-1183. PubMed ID: 34772792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.